MedTrace Logo

Study of Vanadium Supplement in Patients With Impaired Glucose Tolerance

NCT00561132 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2007-11-20

No results posted yet for this study

Summary

The purpose of this study was to evaluate if the vanadium can improve the insulin sensitivity in patients with impaired glucose tolerance. Secondary purpose of this study was to assess changes on metabolic profile, weight and blood pressure.

Conditions

  • Prediabetic State

Interventions

DIETARY_SUPPLEMENT

Vanadyl sulfate

50 mg twice daily orally for a period of 4 weeks

OTHER

Magnesium oxide

Validation of similar appearance and weight to the intervention component orally 1 unit (\<50 mg) twice daily for a period of 4 weeks

Sponsors & Collaborators

  • Fondo para el Fomento a la Investigacion Medica

    collaborator UNKNOWN

  • Doctorado en Farmacologia de la Universidad de Guadalajara

    collaborator UNKNOWN

  • Unidad de Investigacion Medica en Epidemiologia Clinica

    lead OTHER

Principal Investigators

  • Omar Jacques-Camarena, MD, MSc · Unidad de Investigacion Medica en Epidemiologia Clinica

  • Manuel González-Ortiz, MD, MSc, PhD · Unidad de Investigacion Medica en Epidemiologia Clinica

  • Esperanza Martínez-Abundis, MD, MSc, PhD · Unidad de Investigacion Medica en Epidemiologia Clinica

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-11-30
Completion
2004-11-30

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00561132 on ClinicalTrials.gov